William Enright - Net Worth and Insider Trading
William Enright Net Worth
The estimated net worth of William Enright is at least $766,746 dollars as of 2024-06-23. William Enright is the CEO of Barinthus Biotherapeutics PLC and owns about 514,923 shares of Barinthus Biotherapeutics PLC (BRNS) stock worth over $679,698. William Enright is the President and CEO of Altimmune Inc and owns about 12,195 shares of Altimmune Inc (ALT) stock worth over $78,048. William Enright is also the Director of Bullfrog AI Holdings Inc and owns about 5,000 shares of Bullfrog AI Holdings Inc (BFRG) stock worth over $9,000. Details can be seen in William Enright's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that William Enright has not made any transactions after 2023-06-14 and currently still holds the listed stock(s).
Transaction Summary of William Enright
William Enright Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William Enright owns 3 companies in total, including Altimmune Inc (ALT) , Barinthus Biotherapeutics PLC (BRNS) , and Bullfrog AI Holdings Inc (BFRG) .
Click here to see the complete history of William Enright’s form 4 insider trades.
Insider Ownership Summary of William Enright
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALT | Altimmune Inc | 2018-05-25 | director & See Remarks |
| BRNS | Barinthus Biotherapeutics PLC | 2023-03-27 | director & Chief Executive Officer |
| BFRG | Bullfrog AI Holdings Inc | 2023-02-13 | director |
William Enright Latest Holdings Summary
William Enright currently owns a total of 3 stocks. Among these stocks, William Enright owns 514,923 shares of Barinthus Biotherapeutics PLC (BRNS) as of March 27, 2023, with a value of $679,698 and a weighting of 88.65%. William Enright owns 12,195 shares of Altimmune Inc (ALT) as of May 25, 2018, with a value of $78,048 and a weighting of 10.18%. William Enright also owns 5,000 shares of Bullfrog AI Holdings Inc (BFRG) as of June 14, 2023, with a value of $9,000 and a weighting of 1.17%.
Latest Holdings of William Enright
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BRNS | Barinthus Biotherapeutics PLC | 2023-03-27 | 514,923 | 1.32 | 679,698 |
| ALT | Altimmune Inc | 2018-05-25 | 12,195 | 6.40 | 78,048 |
| BFRG | Bullfrog AI Holdings Inc | 2023-06-14 | 5,000 | 1.80 | 9,000 |
Holding Weightings of William Enright
William Enright Form 4 Trading Tracker
According to the SEC Form 4 filings, William Enright has made a total of 1 transactions in Barinthus Biotherapeutics PLC (BRNS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Barinthus Biotherapeutics PLC is the sale of 15,000 shares on March 27, 2023, which brought William Enright around $36,300.
According to the SEC Form 4 filings, William Enright has made a total of 0 transactions in Altimmune Inc (ALT) over the past 5 years. The most-recent trade in Altimmune Inc is the acquisition of 43 shares on May 25, 2018, which cost William Enright around $663.
According to the SEC Form 4 filings, William Enright has made a total of 1 transactions in Bullfrog AI Holdings Inc (BFRG) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Bullfrog AI Holdings Inc is the acquisition of 5,000 shares on June 14, 2023, which cost William Enright around $20,250.
Insider Trading History of William Enright
- 1
William Enright Trading Performance
GuruFocus tracks the stock performance after each of William Enright's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William Enright is -31.75%. GuruFocus also compares William Enright's trading performance to market benchmark return within the same time period. The performance of stocks bought by William Enright within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William Enright's insider trading performs compared to the benchmark.
Performance of William Enright
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.68 | | | | | |
| Relative Return to S&P 500(%) | 0.24 | | | | | |
William Enright Ownership Network
William Enright Owned Company Details
What does Altimmune Inc do?
Who are the key executives at Altimmune Inc?
William Enright is the director & See Remarks of Altimmune Inc. Other key executives at Altimmune Inc include Chief Financial Officer Richard I Eisenstadt , Chief Medical Officer Matthew Scott Harris , and Chief Business Officer Raymond M Jordt .
Altimmune Inc (ALT) Insider Trades Summary
Over the past 18 months, William Enright made no insider transaction in Altimmune Inc (ALT). Other recent insider transactions involving Altimmune Inc (ALT) include a net purchase of 9,300 shares made by David Drutz , a net purchase of 10,000 shares made by Richard I Eisenstadt , and a net purchase of 10,000 shares made by Matthew Scott Harris .
In summary, during the past 3 months, insiders sold 0 shares of Altimmune Inc (ALT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Altimmune Inc (ALT) were sold and 29,300 shares were bought by its insiders, resulting in a net purchase of 29,300 shares.
Altimmune Inc (ALT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Altimmune Inc Insider Transactions
William Enright Mailing Address
Above is the net worth, insider trading, and ownership report for William Enright. You might contact William Enright via mailing address: 910 Clopper Road, Suite 201s, Gaithersburg Md 20878.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
